• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神科医生在精神科护理中关于艾滋病毒暴露前预防(PrEP)处方和管理的经验、培训需求及偏好

Psychiatrists' Experiences, Training Needs, and Preferences Regarding Prescription and Management of HIV Pre-exposure Prophylaxis (PrEP) Within Psychiatric Care.

作者信息

Bunting Samuel R, Feinstein Brian A, Vidyasagar Nitin, Wilson Allison, Schneider John, Ehsan Dustin A, Hazra Aniruddha

机构信息

Department of Psychiatry and Behavioral Neuroscience The University of Chicago Medicine Chicago Illinois USA.

Department of Psychology College of Health Professions Rosalind Franklin University North Chicago Illinois USA.

出版信息

Psychiatr Res Clin Pract. 2024 Sep 18;6(4):151-163. doi: 10.1176/appi.prcp.20240069. eCollection 2024 Winter.

DOI:10.1176/appi.prcp.20240069
PMID:39669536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11633549/
Abstract

BACKGROUND

People living with mental illness (PLWMI) experience a disproportionate prevalence and incidence of HIV. Preventing HIV among PLWMI is a priority for multiple domestic public health agencies. As key clinicians for this group, psychiatrists may have an important role to play in increasing PrEP use among PLWMI.

METHODS

A national survey of psychiatrists ( = 880) about integrating PrEP prescription into psychiatric practice was conducted between November 2022-October 2023. Specifically, we inquired about experiences with PrEP prescription, patient request for PrEP, and interest in prescribing PrEP. We also inquired about barriers to PrEP prescription in psychiatry and preferred models for implementing PrEP prescription in psychiatry.

RESULTS

We found that 19.3% of psychiatrists had received a request for PrEP from a patient, 17.3% had prescribed, and 53.9% were interested in prescribing. The greatest percentage of psychiatrists who prescribed PrEP were practicing primarily in inpatient psychiatry (28.8%). Practicing in one of the federal (EHE) priority jurisdictions (aOR = 2.08 [1.23-3.54],  = 0.003) and greater self-confidence in PrEP-related tasks (aOR = 2.10 [1.67-2.65],  < 0.001) were associated with higher likelihood of PrEP prescription. Limited knowledge of PrEP was the barrier endorsed by the greatest percentage of psychiatrists (76.3%). Most preferred a hypothetical model in which a psychiatrist prescribed an initial course of PrEP with prompt primary care or infectious disease follow-up (63.1%).

CONCLUSION

Most psychiatrists were interested in prescribing PrEP. Training is needed to enable PrEP implementation in psychiatric practice including development of collaborative practice models to engage psychiatrists across a diversity of settings.

摘要

背景

精神疾病患者(PLWMI)感染艾滋病毒的患病率和发病率不成比例。在PLWMI中预防艾滋病毒是多个国内公共卫生机构的优先事项。作为该群体的关键临床医生,精神科医生在增加PLWMI中暴露前预防(PrEP)的使用方面可能发挥重要作用。

方法

在2022年11月至2023年10月期间对880名精神科医生进行了一项关于将PrEP处方纳入精神科实践的全国性调查。具体而言,我们询问了PrEP处方经验、患者对PrEP的需求以及开具PrEP的意愿。我们还询问了精神科中PrEP处方的障碍以及精神科实施PrEP处方的首选模式。

结果

我们发现,19.3%的精神科医生收到过患者对PrEP的需求,17.3%的医生开具过PrEP,53.9%的医生有开具PrEP的意愿。开具PrEP的精神科医生中,最大比例的主要从事住院精神科工作(28.8%)。在联邦指定的重点辖区之一执业(调整后比值比[aOR]=2.08[1.23 - 3.54],P = 0.003)以及对PrEP相关任务更有自信(aOR = 2.10[1.67 - 2.65],P < 0.001)与开具PrEP的可能性更高相关。PrEP知识有限是大多数精神科医生认可的障碍(76.3%)。大多数人倾向于一种假设模式,即精神科医生开具PrEP初始疗程,并由初级保健或传染病专科医生及时跟进(63.1%)。

结论

大多数精神科医生有开具PrEP的意愿。需要进行培训,以在精神科实践中实施PrEP,包括开发协作实践模式,让不同环境下的精神科医生参与其中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb27/11633549/5ddfc5f13936/RCP2-6-151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb27/11633549/339e324471ac/RCP2-6-151-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb27/11633549/d6ea16b68e32/RCP2-6-151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb27/11633549/5ddfc5f13936/RCP2-6-151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb27/11633549/339e324471ac/RCP2-6-151-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb27/11633549/d6ea16b68e32/RCP2-6-151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb27/11633549/5ddfc5f13936/RCP2-6-151-g001.jpg

相似文献

1
Psychiatrists' Experiences, Training Needs, and Preferences Regarding Prescription and Management of HIV Pre-exposure Prophylaxis (PrEP) Within Psychiatric Care.精神科医生在精神科护理中关于艾滋病毒暴露前预防(PrEP)处方和管理的经验、培训需求及偏好
Psychiatr Res Clin Pract. 2024 Sep 18;6(4):151-163. doi: 10.1176/appi.prcp.20240069. eCollection 2024 Winter.
2
Preferences for PrEP Implementation and Engagement in the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County.在一个“终结艾滋病流行”重点县接受精神科护理的患者中,对艾滋病病毒暴露前预防(PrEP)实施及参与PrEP护理连续过程的偏好
J Acquir Immune Defic Syndr. 2025 Apr 7. doi: 10.1097/QAI.0000000000003675.
3
Psychiatry and Family Medicine Residents' Likelihood of Prescribing HIV Pre-exposure Prophylaxis to Patients With Mental Illness and HIV Vulnerability.精神科和家庭医学住院医师为有精神疾病和 HIV 易感性的患者开 HIV 暴露前预防药物的可能性。
J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):231-240. doi: 10.1097/QAI.0000000000003423.
4
Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system.在安全网医疗系统中,初级保健提供者实施HIV暴露前预防所需的知识。
Prev Med Rep. 2020 Nov 28;20:101266. doi: 10.1016/j.pmedr.2020.101266. eCollection 2020 Dec.
5
Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.县级预防前预防性覆盖估计方法及其在美国终结艾滋病毒流行司法管辖区的应用。
Ann Epidemiol. 2020 Apr;44:16-30. doi: 10.1016/j.annepidem.2020.01.004. Epub 2020 Jan 13.
6
Understanding Opportunities for Prescribing Pre-exposure Prophylaxis (PrEP) at Two Academic Medical Centers in a High Priority Jurisdiction for Ending the HIV Epidemic.在一个对终结艾滋病流行具有高度优先地位的司法管辖区的两家学术医疗中心,了解开具暴露前预防(PrEP)药物的机会。
medRxiv. 2024 Jul 26:2024.07.25.24310992. doi: 10.1101/2024.07.25.24310992.
7
Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.简要报告:城市保障体系中的 HIV 暴露前预防用药开方情况。
J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):e17-e21. doi: 10.1097/QAI.0000000000002767.
8
Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder.运用名义群体技术,确定使用组合同日暴露前预防和阿片类药物使用障碍治疗药物预防 HIV 的障碍和促进因素。
Harm Reduct J. 2022 Oct 28;19(1):120. doi: 10.1186/s12954-022-00703-8.
9
Health Care Providers' Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis.医疗服务提供者对可能有助于开具HIV暴露前预防(PrEP)处方的诊所基础设施和实践模式的看法:一项定性元综合分析。
Health Promot Pract. 2022 Nov;23(6):999-1014. doi: 10.1177/15248399211038364. Epub 2021 Sep 22.
10
Assessing Knowledge, Practices, and Barriers to PrEP and nPEP Prescription Among Texas Healthcare Providers.评估德克萨斯州医疗保健提供者中暴露前预防(PrEP)和暴露后预防(nPEP)处方的知识、实践及障碍。
Healthcare (Basel). 2024 Nov 20;12(22):2315. doi: 10.3390/healthcare12222315.

引用本文的文献

1
Preferences for PrEP Implementation and Engagement in the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County.在一个“终结艾滋病流行”重点县接受精神科护理的患者中,对艾滋病病毒暴露前预防(PrEP)实施及参与PrEP护理连续过程的偏好
J Acquir Immune Defic Syndr. 2025 Apr 7. doi: 10.1097/QAI.0000000000003675.

本文引用的文献

1
Preexposure Prophylaxis (PrEP) for HIV Prevention at Outpatient Substance Use Treatment Facilities, United States, 2021.2021 年美国门诊物质使用治疗机构中的 HIV 预防暴露前预防(PrEP)。
Am J Public Health. 2024 Aug;114(8):833-837. doi: 10.2105/AJPH.2024.307699. Epub 2024 May 30.
2
Improving Delivery and Use of HIV Pre-Exposure Prophylaxis in the US: A Systematic Review of Implementation Strategies and Adjunctive Interventions.提高美国 HIV 暴露前预防措施的提供和使用:实施策略和辅助干预措施的系统评价。
AIDS Behav. 2024 Jul;28(7):2321-2339. doi: 10.1007/s10461-024-04331-0. Epub 2024 Apr 2.
3
Initiating pre-exposure prophylaxis in the inpatient setting: a quality improvement project.
在住院环境中启动暴露前预防:一项质量改进项目。
BMJ Open Qual. 2024 Jan 17;13(1):e002416. doi: 10.1136/bmjoq-2023-002416.
4
Availability of Testing for Sexually Transmitted Infections and HIV in U.S. Outpatient Mental Healthcare Settings.美国门诊精神卫生保健环境中性传播感染和 HIV 检测的可及性。
AIDS Behav. 2024 Mar;28(3):1029-1038. doi: 10.1007/s10461-023-04211-z. Epub 2023 Oct 26.
5
Association between depression and HIV infection vulnerable populations in United States adults: a cross-sectional analysis of NHANES from 1999 to 2018.1999 年至 2018 年 NHANES 横断面分析:美国成年人中抑郁与 HIV 感染易感染人群的关系。
Front Public Health. 2023 Jun 1;11:1146318. doi: 10.3389/fpubh.2023.1146318. eCollection 2023.
6
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.抗逆转录病毒药物治疗和预防成人 HIV 感染:美国国际抗病毒学会 2022 年推荐意见。
JAMA. 2023 Jan 3;329(1):63-84. doi: 10.1001/jama.2022.22246.
7
Demographic factors, psychiatric and physical comorbidities associated with starting preexposure prophylaxis in a nationally distributed cohort.在一个全国性队列中,与开始暴露前预防相关的人口统计学因素、精神和身体合并症。
Prev Med. 2022 Nov;164:107344. doi: 10.1016/j.ypmed.2022.107344. Epub 2022 Nov 9.
8
HIV Pre-Exposure Prophylaxis in the Emergency Department: A Systematic Review.急诊科 HIV 暴露前预防:系统评价。
Ann Emerg Med. 2023 Apr;81(4):468-481. doi: 10.1016/j.annemergmed.2022.07.015. Epub 2022 Sep 15.
9
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine.长效注射治疗在 HIV 感染者中的应用:从精神病学和成瘾医学中汲取经验展望未来。
AIDS Behav. 2023 Jan;27(1):10-24. doi: 10.1007/s10461-022-03817-z. Epub 2022 Sep 5.
10
Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use.有商业保险且可能有注射吸毒行为者的 HIV 暴露前预防用药开具情况的流行率。
JAMA Netw Open. 2022 Jul 1;5(7):e2221346. doi: 10.1001/jamanetworkopen.2022.21346.